You are on page 1of 13

© IBD Registry.

All rights reserved

ibdregistry.org.uk

Audit and IBD Registry where next?
Dr Ian Arnott & Dr Stuart Bloom

© IBD Registry. All rights reserved

ibdregistry.org.uk

Registry symposium 2016
• The registry is becoming the vehicle for
ongoing data collection for audit and QI in
the UK
• Aims of data collection 2016-7
• Focus on biologics KPIs and local data
reporting
• On going research
• Plans for future funding
© IBD Registry. All rights reserved

ibdregistry.org.uk

UK Inflammatory Bowel
Disease (IBD) Audit:
Update for 2016

Ian Arnott, Clinical Director,
UK IBD Audit
22nd June 2016

Where next for the IBD
programme?

IBD is no longer a priority topic area for NHS
England
HQIP funding to integrate audit, QI and
registry
2016-2017
Aim to continue to deliver quality
improvement to the IBD community through
integration with an IBD Registry

Drug efficacy – Response
at 3/12
Time to initial Rx Total
Humira

91%

Inflectra/Remsim
a
91%
Remicade

81%

CD patients – defined as >3 point drop in HBI

Over view of programme
of work
Aim
To develop and sustain a culture
of quality improvement within
the IBD community.
By
Supporting sites to transition
from the audit to the using the
IBD Registry as the system for
data capture.

Helping IBD teams to
make improvements in
care…
How?

‘Embed quality improvement in the IBD
Registry’
Initiatives include:
Training, workshops, case studies
Instant / frequent feedback on data
entered – data visualisation

6 performance / quality
indicators
1.
Whether
pre-treatment
screening
was
For patients
newly-started
on a biological
therapy
undertaken
2. Whether there was a post-induction
review (at 3 months post initiation)
3. Whether a formal assessment of disease
activity was undertaken at this time
4. Whether there was a 12 month review
5. Whether a formal assessment of disease
activity was undertaken at this time
6. Whether there is a record of Registry
consent having been discussed with all
patients

Hospital team enters
data: instant provision of
performance against
national benchmarks

What’s happening now?
• Hospital teams invited to
register across the UK for the
next phase of work.
• IBD programme remains on
quality accounts.
• Keep entering data on
Biologics audit web tool.
www.rcplondon.ac.uk/ibd
• Web tool and data import
function will enable transfer of

Acknowledgements
CEEu




CCUK

Aimee Protheroe
Susan Murray
Kajal Mortier
Kevin Stewart
Rhona Buckingham

HQIP

– David Barker
– Elaine Steven

BSG
– Ian Forgacs
– Jon Rhodes
– John Williams

– Jane Ingram

Contact: Ibd.audit@rcplondon.ac.uk
020 3075 1566/1565
www.rcplondon.ac.uk